Hospital
Saint Thomas Highlands Hospital, LLC
Saint Thomas Highlands Hospital, LLC was paid $3.33M by Medicaid between Jan 2018 and Dec 2024, across 65 billing codes. Its largest line is 99283, emergency room visit (moderate) — 41% of everything it billed.
33Billing provider infoSAINT THOMAS HIGHLANDS HOSPITAL, LLC
SPARTA, TN 38583
SPARTA, TN 38583
33aNPI1922487966assigned 05/22/2015
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.33M
24GClaims79,359
24DCodes billed65
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Tennessee
Rank by total paid#53 of 71
Median peer was paid$6.96M
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DAVIS, LISA controls 12+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,520 | $371K | |
| 2019 | 10,670 | $515K | |
| 2020 | 7,759 | $341K | |
| 2021 | 11,849 | $488K | |
| 2022 | 14,417 | $569K | |
| 2023 | 18,576 | $637K | |
| 2024incomplete | 8,568 | $411K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 41% | 11,634 | 10,822 | $1.38M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 39% | 7,550 | 6,797 | $1.30M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.6% | 1,797 | 1,562 | $288K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.9% | 2,009 | 1,845 | $64K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.5% | 727 | 690 | $51K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.3% | 1,754 | 1,651 | $43K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.0% | 4,638 | 4,028 | $34K |
| 84484 | <1% | 3,138 | 2,462 | $19K | |
| G0378 | Hospital observation service, per hour | <1% | 107 | 92 | $16K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 344 | 306 | $15K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,782 | 4,221 | $13K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 282 | 262 | $12K |
53 more codes
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 54 | $11K |
| 80053 | Comprehensive metabolic panel | <1% | 5,464 | $11K |
| 85027 | <1% | 3,558 | $8K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,000 | $8K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 292 | $6K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 334 | $6K |
| 84703 | <1% | 1,358 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,562 | $5K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,049 | $5K |
| 83690 | <1% | 1,352 | $4K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 924 | $4K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,511 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,459 | $3K |
| 83880 | <1% | 565 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 132 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 584 | $2K |
| 87070 | <1% | 555 | $2K | |
| 83605 | <1% | 697 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,803 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 420 | $1K |
| 81001 | <1% | 2,197 | $1K | |
| 83735 | <1% | 557 | $943.53 | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 30 | $645.06 |
| 80076 | <1% | 265 | $467.24 | |
| 87040 | <1% | 176 | $344.93 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 30 | $271.99 |
| 73562 | <1% | 13 | $213.96 | |
| 85379 | <1% | 30 | $162.12 | |
| 81003 | <1% | 415 | $161.05 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 195 | $131.10 |
| 85380 | <1% | 16 | $97.86 | |
| 85610 | <1% | 112 | $77.30 | |
| 96376 | <1% | 18 | $32.10 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 14 | $25.62 |
| 82550 | <1% | 15 | $25.42 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 78 | $22.62 |
| 36415 | Collection of venous blood by venipuncture | <1% | 144 | $16.24 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 15 | $1.80 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 778 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 271 | $0.00 |
| 73630 | 0% | 15 | $0.00 | |
| 76000 | 0% | 39 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 16 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 2,548 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 1,404 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 600 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 71 | $0.00 |
| A9270 | Non-covered item or service | 0% | 371 | $0.00 |
| J3490 | Unclassified drugs | 0% | 265 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 33 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 160 | $0.00 |
| 91301 | 0% | 18 | $0.00 | |
| 88304 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAVIS, LISA (CFO)
| Provider | Location | Paid |
|---|---|---|
| Saint Thomas River Park Hospital, LLC | Mcminnville, TN | $8.41M |
| Saint Thomas West Hospital | Nashville, TN | $7.14M |
| Meeting Milestones Early Intervention Services, LLC | Gaffney, SC | $6.63M |
| Saint Thomas West Hospital | Nashville, TN | $3.68M |
| Public Health Solutions | Brooklyn, NY | $2.10M |
| Nursing and Therapy Services of Colorado INC | Colorado Springs, CO | $1.05M |
| Saint Thomas Hickman Hospital | Centerville, TN | $924K |
| Saint Thomas Stones River Hospital, LLC | Woodbury, TN | $554K |
| Metro Anesthesia, PLLC | Ridgeland, MS | $261K |
| Talking Toddlers LLC | Simpsonville, SC | $16K |
| Royal Paradise Cente LLC | West Palm Beach, FL | $4K |
| Lisa A. Davis, M.D., P.A. | San Antonio, TX | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.